Why big pharma had a responsibility to profit from the pandemic
The pharmaceutical company Pfizer expects to earn up to US$26 billion (£18 billion) this year from the sale of its COVID-19 vaccine. Profits for the first quarter of 2021 are apparently 44% higher than they were a year ago. This has led some to ask whether it is right for these big drug companies to effectively profit from the pandemic – especially in light of commitments from competitors Johnson & Johnson and AstraZeneca to sell their vaccines on a non-profit basis. From a moral point of view, one might think such huge sums are unacceptable when so many industries – the arts, hospitali...
Source: theconversation.com